Purpose: To report a cluster of high incidence of noninfectious inflammatory reaction shortly after bevacizumab injection.
Methods: Data were collected from medical records of consecutive patients who underwent bevacizumab injections and presented with acute uveitis within 1-4 days.
Results: All 7 patients were injected intravitreally with bevacizumab from different batches and presented with visual deterioration.